HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Use of Bradyl 250 in the early phase of myocardial infarct and in the danger syndrome].

AuthorsM M Pauchant, A Giard, A Decalf, Y Decalf, A Delmon, S Goethals, J J Waucampt
JournalLille medical : journal de la Faculte de medecine et de pharmacie de l'Universite de Lille (Lille Med) Vol. 21 Issue 7 Suppl 3 Pg. 595-601 (Sep 1976) ISSN: 0024-3507 [Print] France
Vernacular TitleUtilisation du Bradyl 250 à la phase précoce de l'infarctus du myocarde et dans le syndrome de menace
PMID792604 (Publication Type: Clinical Trial, Journal Article)
Chemical References
  • Anti-Arrhythmia Agents
  • Naphthalenes
  • Oximes
Topics
  • Aged
  • Anti-Arrhythmia Agents (therapeutic use)
  • Clinical Trials as Topic
  • Female
  • Humans
  • Male
  • Middle Aged
  • Myocardial Infarction (drug therapy)
  • Naphthalenes (therapeutic use)
  • Oximes (therapeutic use)
  • Syndrome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: